USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
16.90
-0.32 (-1.86%)
At close: Apr 2, 2026, 4:00 PM EDT
17.00
+0.10 (0.59%)
After-hours: Apr 2, 2026, 7:00 PM EDT

USANA Health Sciences Cash Flow Statement

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
FY 2025FY 2023FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
11.4842.0663.7969.35116.51
Depreciation & Amortization
39.722.2320.421.4122.19
Stock-Based Compensation
13.8314.5614.613.3314.3
Other Adjustments
0.42-4.85-0.14-0.961.29
Changes in Inventories
-34.69-2.122.3515.8-14.7
Changes in Accounts Payable
5.2-1.27-0.43-2.66-4.57
Changes in Other Operating Activities
-13.6-9.62-29.92-12.37-13.79
Operating Cash Flow
22.3560.9970.64103.9121.23
Operating Cash Flow Growth
-63.36%-13.66%-32.01%-14.29%-24.42%
Capital Expenditures
-13.82-10.07-14.49-10.4-12.76
Sale of Property, Plant & Equipment
3.910.060.020.010.02
Payments for Business Acquisitions
--203.34--6.53-
Other Investing Activities
-0.210.262.54.56-1.44
Investing Cash Flow
-10.13-213.09-11.98-12.37-14.19
Short-Term Debt Issued
17.623.691.5411-
Short-Term Debt Repaid
-26.6-1.47-0.75-11-
Net Short-Term Debt Issued (Repaid)
-922.220.790-
Repurchase of Common Stock
-27.51-9.44-11.6-25.38-177.84
Net Common Stock Issued (Repurchased)
-27.51-9.44-11.6-25.38-177.84
Other Financing Activities
-4.1-3.22-3.43-4.71-3.58
Financing Cash Flow
-40.69.55-14.24-30.09-181.41
Effect of Exchange Rate Changes on Cash and Cash Equivalents
5.11-6.19-2.5-13.782.09
Net Cash Flow
-23.27-148.7441.9347.67-72.28
Free Cash Flow
8.5350.9256.1593.5108.46
Free Cash Flow Growth
-83.26%-9.31%-39.95%-13.79%-25.36%
FCF Margin
0.92%5.96%6.10%9.36%9.14%
Free Cash Flow Per Share
0.462.662.904.845.33
Levered Free Cash Flow
-15.4463.442.4881.1392.88
Unlevered Free Cash Flow
-6.8535.6935.8580.4992.57
Updated Jan 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q